일신바이오 Stock: price and insider trades · South Korea
1 insider bought shares over the last 90 days, the latest by 홍성대, filed 05 Nov 2026.
일신바이오: what insiders have been doing
This page follows insider dealings at 일신바이오 as filed with DART (FSS), a company from the Health Care sector. Between 5 November 2025 and 5 November 2026, 2 insiders published 4 filings.
Every open-market trade in the period is a purchase: 4 purchases worth €269k, from 2 insiders, and not a single sale. The amount is not disclosed for 3 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 major shareholder, 1 board member and 1 chief executive. The largest single trade was a purchase of €269k by 홍중기, published on 2 June 2026.
The most recent open-market purchase was published on 5 November 2026, 5 days ago.
With 4 filings in twelve months, the company is quieter than the median of 7 filings across the 2,656 companies we follow on the same exchange. Since 2021, the database holds 7 purchases and no sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 200,000 sharesShareKRXDART:20261105000026Canonical exit: 3 Feb 2027 (T+90)
- Other0DART
- 537,323 sharesKRXDART:20260604000230Canonical exit: 2 Sept 2026 (T+90)
- 394,758 shares@ ₩1,202.00100.0% of flowShareKRXDART:20260602000351Canonical exit: 31 Aug 2026 (T+90)
- 142,565 sharesShareKRXDART:20260518000016Canonical exit: 16 Aug 2026 (T+90)
- ShareKRXDART:20240725000459Canonical exit: 12 Nov 2020 (T+90)
- 119,505 sharesKRXDART:20240725000239Canonical exit: 22 Oct 2024 (T+90)
- ShareKRXDART:20240725000189Canonical exit: 21 Oct 2024 (T+90)
- ●Executives0DART
9 of 9 declarations
About 일신바이오
Ilshin Bio is in the healthcare and pharmaceutical sector, listed on the XKRX market. The company specializes in the development of biopharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
